Table 2 Laboratory tests before aspirin treatment
From: Effect of different doses of aspirin on the prognosis of Kawasaki disease
Group | 1 | 2 | 3 | P-value |
|---|---|---|---|---|
N | 510 | 1487 | 372 | |
WBC1(10^9/L) | 15.15 (11.91–19.37) | 15.57 (12.24–19.80) | 15.42 (12.70–19.86) | 0.276 |
HB1(g/L) | 111.64 ± 11.34 | 110.42 ± 11.34 | 108.48 ± 11.05 | <0.001 |
PLT1(10^9/L) | 379.24 ± 135.27 | 388.75 ± 136.16 | 388.44 ± 143.93 | 0.392 |
ANC1(10^9/L) | 10.79 ± 5.15 | 10.76 ± 4.99 | 10.64 ± 4.80 | 0.903 |
CRP1(mg/L) | 70.10 (35.00–113.87) | 75.00 (42.49–118.01) | 81.40 (47.55–117.00) | 0.196 |
ESR1(mm/h) | 37.50 ± 17.14 | 36.99 ± 16.90 | 35.84 ± 17.56 | 0.412 |
ALT1(u/L) | 35.00 (17.00–91.00) | 34.00 (18.00–92.50) | 33.00 (19.00–75.00) | 0.552 |
AST1(u/L) | 33.50 (25.00–50.25) | 31.50 (24.00–51.00) | 29.00 (24.00–52.00) | 0.225 |
Albumin1(g/L) | 36.52 ± 6.26 | 36.19 ± 6.28 | 34.63 ± 6.58 | <0.001 |
PT1(s) | 13.82 ± 0.99 | 13.82 ± 1.05 | 13.97 ± 1.63 | 0.165 |
APTT1(s) | 43.34 ± 5.94 | 43.71 ± 6.71 | 43.11 ± 5.99 | 0.331 |
FIB1(g/L) | 1.23 (0.85–2.16) | 1.43 (0.87–2.16) | 1.37 (0.82–2.28) | 0.002 |
TT1(s) | 14.84 ± 0.90 | 14.89 ± 1.23 | 14.87 ± 1.09 | 0.804 |
D-Dimers1 (ug/ml) | 1.23 (0.85–2.16) | 1.43 (0.87–2.16) | 1.37 (0.82–2.28) | 0.328 |